Effects of propionyl-carnitine in patients with type 2 diabetes and peripheral vascular disease: results of a pilot trial

To assess the efficacy of propionyl-carnitine (PC) in patients with type 2 diabetes and peripheral arterial disease (PAD). This was an open pharmacodynamic study. Twenty-four obese patients with type 2 diabetes and PAD (stage IIb) were enrolled in the study. After an initial run-in period of 7 days...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Drugs in R&D 2004, Vol.5 (4), p.185-190
Hauptverfasser:	Ragozzino, Giovanni, Mattera, Edi, Madrid, Elisa, Salomone, Patrizia, Fasano, Carmela, Gioia, Filomena, Acerra, Giusy, del Guercio, Raffaele, Federico, Pasquale
Format:	Artikel
Sprache:	eng
Schlagworte:	Blood Glucose - drug effects Carnitine - administration & dosage Carnitine - analogs & derivatives Carnitine - therapeutic use Diabetes Mellitus, Type 2 - complications Diabetes Mellitus, Type 2 - drug therapy Female Humans Injections, Intravenous Male Middle Aged Peripheral Vascular Diseases - complications Peripheral Vascular Diseases - drug therapy Pilot Projects Treatment Outcome Vasodilator Agents - administration & dosage Vasodilator Agents - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!